Search
for
Sort by
Research 121–150 of 183
- Dermatologic care of patients with differences of sex development
- Wokeness in Our Practice
- Hormonal Therapies for Individuals with Intersex Conditions
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
- Polycystic ovary syndrome
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- 5alpha-reductase: history and clinical importance.
- Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia
- The Roles of Non-coding RNA in the Development and Regeneration of Hair Follicles: Current Status and Further Perspectives
- Training requirements and recommendation for the specialty of dermatology and venereology <i>European Standards of Postgraduate Medical Specialist Training</i>
- Expanding the Scope of a Dynamic Perspective on Positive Adolescent Sexual Development
- IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male
- Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis
- Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Identification of a Rare Variant in the <i>SRD5A2</i> Gene in Siblings With 46,XY Disorders of Sexual Development
- Satisfaction of Patients with Androgenetic Alopecia from a Topical Treatment with TH07 - A New Novel Combination of Substances that Safely Encourage Hair Growth
- The Quality of Life and Psychosocial Impact on Female Pattern Hair Loss
- Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency
- Polycystic ovary syndrome: Diagnosis and management
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Autologous Micrograft Technology (AMT) and Finasteride for the Management of Androgenic Alopecia – A Systematic Review and Meta-analysis of the Efficacy and Safety
- Does Hair Loss Impact Mood, Self-esteem, Body Image, and Quality of Life in Patients of Androgenetic Alopecia?
- Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome
- Association between psychosocial distress, sexual disorders, self-esteem and quality of life with male androgenetic alopecia: a population-based study with men at age 46